基于SII和CRP构建颅内血管狭窄风险预测模型
Constructing a Model to Predict the Risk of Intracranial Vascular Stenosis Using SII and CRP
DOI: 10.12677/acm.2025.151160, PDF,    科研立项经费支持
作者: 李从芳, 林 巧, 潘玺月:青岛大学附属医院全科医学科,山东 青岛;王乃东*:青岛大学附属医院神经介入科,山东 青岛
关键词: 颅内血管狭窄全身免疫炎症指数C反应蛋白预测模型Intracranial Stenosis Systemic Immune-Inflammation Index C-Reactive Protein Prediction Model
摘要: 目的:颅内血管狭窄与脑梗死的严重程度相关,基于患者入院时病史资料、实验室指标开发预测模型识别颅内血管狭窄高危人群。方法:收集2022年9月至2023年4月于青岛大学附属医院住院行MRA的839例患者,使用单因素和多因素Logistics回归分析,筛选与颅内动脉狭窄相关的预测因子,构建颅内动脉狭窄风险预测评估表,并通过模型的区分度、校准度,来评估预测模型的临床实用性,采用1000次Bootstrapping法进行内部验证。结果:根据多因素Logistics筛选得到年龄、高血压、糖尿病、吸烟、体重指数、高脂血症、SII、CRP与颅内血管狭窄相关,构建风险预测模型,该模型有良好的区分度(AUC = 0.816 95%CI 0.787~0.845)和临床预测性(HL = 0.834),内部验证时模型也表现出良好的区分度(AUC = 0.820 95%CI 0.791~0.849)和临床预测性(HL = 0.530)。结论:基于年龄、高血压、糖尿病、吸烟、体重指数、高脂血症、SII、CRP等因素构建的评分表可以用于预测颅内血管狭窄的风险,具有潜在临床应用价值。
Abstract: Objective: Intracranial vascular stenosis is associated with the severity of cerebral infarction. The aim of this study was to develop a user-friendly model for predicting the risk of intracranial arterial stenosis using admission history and laboratory indices. Methods: We conducted a retrospective analysis of clinical data from 839 patients who underwent MRA between September 2022 and April 2023 in Affiliated Hospital of Qingdao University. We identified risk factors associated with intracranial stenosis through univariate and multivariate logistic regression analyses. The prediction and evaluation table of intracranial artery stenosis risk was constructed, and the clinical practicability of the prediction model was evaluated by the degree of differentiation and calibration of the model. The 1000 times Bootstrapping method was used for internal verification. Results: According to multi-factor Logistics screening, age, hypertension, diabetes, smoking, body mass index, hyperlipidemia, SII and CRP are related to intracranial vascular stenosis, and a risk prediction model is constructed. The model had good differentiation (AUC = 0.816 95%CI 0.787~0.845) and clinical prediction (HL = 0.834), the model also showed good differentiation (AUC = 0.820 95%CI 0.791~0.849) and clinical prediction (HL = 0.530) during internal validation. Conclusion: A score scale based on age, hypertension, diabetes, smoking, body mass index, hyperlipidemia, SII, CRP and other factors can be used to predict the risk of intracranial vascular stenosis, which has potential clinical application value.
文章引用:李从芳, 林巧, 潘玺月, 王乃东. 基于SII和CRP构建颅内血管狭窄风险预测模型[J]. 临床医学进展, 2025, 15(1): 1209-1217. https://doi.org/10.12677/acm.2025.151160

参考文献

[1] 孙瑄, 杨明, 余泽权, 等. 症状性颅内动脉粥样硬化性狭窄血管内治疗中国专家共识2022 [J]. 中国卒中杂志, 2022, 17(8): 863-888.
[2] Dong, X., Nao, J. and Gao, Y. (2019) Peripheral Monocyte Count Predicts Outcomes in Patients with Acute Ischemic Stroke Treated with RTPA Thrombolysis. Neurotoxicity Research, 37, 469-477. [Google Scholar] [CrossRef] [PubMed]
[3] Matsui, R., Nakagawa, T., Takayoshi, H., Onoda, K., Oguro, H., Nagai, A., et al. (2016) A Prospective Study of Asymptomatic Intracranial Atherosclerotic Stenosis in Neurologically Normal Volunteers in a Japanese Cohort. Frontiers in Neurology, 7, Article 39. [Google Scholar] [CrossRef] [PubMed]
[4] Yang, D., Liu, M., Khasiyev, F., Rundek, T., Del Brutto, V.J., Cheung, K., et al. (2023) Immune Markers Are Associated with Asymptomatic Intracranial Large Artery Stenosis and Future Vascular Events in NOMAS. Stroke, 54, 3030-3037. [Google Scholar] [CrossRef] [PubMed]
[5] Corriere, T., Di Marca, S., Cataudella, E., Pulvirenti, A., Alaimo, S., Stancanelli, B., et al. (2018) Neutrophil-to-lymphocyte Ratio Is a Strong Predictor of Atherosclerotic Carotid Plaques in Older Adults. Nutrition, Metabolism and Cardiovascular Diseases, 28, 23-27. [Google Scholar] [CrossRef] [PubMed]
[6] Xia, Y., Xia, C., Wu, L., Li, Z., Li, H. and Zhang, J. (2023) Systemic Immune Inflammation Index (SII), System Inflammation Response Index (SIRI) and Risk of All-Cause Mortality and Cardiovascular Mortality: A 20-Year Follow-Up Cohort Study of 42,875 US Adults. Journal of Clinical Medicine, 12, Article 1128. [Google Scholar] [CrossRef] [PubMed]
[7] Song, Y., Wang, M., Li, Y. and Lian, Y. (2024) The Evaluation Value of Atherogenic Index of Plasma and High-Sensitivity C-Reactive Protein for the Degree of Coronary Artery Lesion in Premature Coronary Artery Disease. BMC Cardiovascular Disorders, 24, Article No. 410. [Google Scholar] [CrossRef] [PubMed]
[8] Hu, X., Sui, Y., Yang, X., Yang, Z., Wang, Q., Yuan, J., et al. (2024) Association of the High-Sensitivity C-Reactive Protein-To-Albumin Ratio with Carotid Atherosclerotic Plaque: A Community-Based Cohort Study. Journal of Inflammation Research, 17, 4027-4036. [Google Scholar] [CrossRef] [PubMed]
[9] Poorthuis, M.H.F., Sherliker, P., Morris, D.R., Massa, M.S., Clarke, R., Staplin, N., et al. (2021) Development and Internal Validation of a Risk Score to Detect Asymptomatic Carotid Stenosis. European Journal of Vascular and Endovascular Surgery, 61, 365-373. [Google Scholar] [CrossRef] [PubMed]
[10] Högberg, D., Mani, K., Wanhainen, A. and Svensjö, S. (2018) Clinical Effect and Cost-Effectiveness of Screening for Asymptomatic Carotid Stenosis: A Markov Model. European Journal of Vascular and Endovascular Surgery, 55, 819-827. [Google Scholar] [CrossRef] [PubMed]
[11] Huang, J., Degnan, A.J., Liu, Q., Teng, Z., Yue, C.S., Gillard, J.H., et al. (2012) Comparison of NASCET and WASID Criteria for the Measurement of Intracranial Stenosis Using Digital Subtraction and Computed Tomography Angiography of the Middle Cerebral Artery. Journal of Neuroradiology, 39, 342-345. [Google Scholar] [CrossRef] [PubMed]
[12] 高鹏. 颅内动脉粥样硬化性狭窄影像学评价专家共识[J]. 中国脑血管病杂志, 2021, 18(8): 575-584.
[13] Arnold, N., Blaum, C., Goßling, A., Brunner, F.J., Bay, B., Ferrario, M.M., et al. (2024) C-Reactive Protein Modifies Lipoprotein(a)-Related Risk for Coronary Heart Disease: The BiomarCaRE Project. European Heart Journal, 45, 1043-1054. [Google Scholar] [CrossRef] [PubMed]
[14] Ma, Y., Leng, X., Dong, Y., Xu, W., Cao, X., Ji, X., et al. (2019) Risk Factors for Intracranial Atherosclerosis: A Systematic Review and Meta-Analysis. Atherosclerosis, 281, 71-77. [Google Scholar] [CrossRef] [PubMed]
[15] Nahab, F., Kingston, C., Frankel, M.R., Dion, J.E., Cawley, C.M., Mitchell, B., et al. (2013) Early Aggressive Medical Management for Patients with Symptomatic Intracranial Stenosis. Journal of Stroke and Cerebrovascular Diseases, 22, 87-91. [Google Scholar] [CrossRef] [PubMed]
[16] Miao, H., Yang, Y., Wang, H., Huo, L., Wang, M., Zhou, Y., et al. (2019) Intensive Lipid-Lowering Therapy Ameliorates Asymptomatic Intracranial Atherosclerosis. Aging and disease, 10, 258-266. [Google Scholar] [CrossRef] [PubMed]
[17] Chung, J., Cha, J., Lee, M.J., Yu, I., Park, M., Seo, W., et al. (2019) Intensive Statin Treatment in Acute Ischaemic Stroke Patients with Intracranial Atherosclerosis: A High-Resolution Magnetic Resonance Imaging Study (STAMINA-MRI Study). Journal of Neurology, Neurosurgery & Psychiatry, 91, 204-211. [Google Scholar] [CrossRef] [PubMed]
[18] Powers, W.J., Clarke, W.R., Grubb, R.L., Videen, T.O., Adams, H.P. and Derdeyn, C.P. (2014) Lower Stroke Risk with Lower Blood Pressure in Hemodynamic Cerebral Ischemia. Neurology, 82, 1027-1032. [Google Scholar] [CrossRef] [PubMed]
[19] Kasner, S.E., Chimowitz, M.I., Lynn, M.J., Howlett-Smith, H., Stern, B.J., Hertzberg, V.S., et al. (2006) Predictors of Ischemic Stroke in the Territory of a Symptomatic Intracranial Arterial Stenosis. Circulation, 113, 555-563. [Google Scholar] [CrossRef] [PubMed]
[20] (2019) 6. Glycemic Targets: Standards of Medical Care in Diabetes—2020. Diabetes Care, 43, S66-S76. [Google Scholar] [CrossRef] [PubMed]
[21] Duncan, M.S., Freiberg, M.S., Greevy, R.A., Kundu, S., Vasan, R.S. and Tindle, H.A. (2019) Association of Smoking Cessation with Subsequent Risk of Cardiovascular Disease. JAMA, 322, 642-650. [Google Scholar] [CrossRef] [PubMed]
[22] Lee, C.D., Folsom, A.R. and Blair, S.N. (2003) Physical Activity and Stroke Risk: A Meta-Analysis. Stroke, 34, 2475-2481. [Google Scholar] [CrossRef] [PubMed]
[23] Kleindorfer, D.O., Towfighi, A., Chaturvedi, S., Cockroft, K.M., Gutierrez, J., Lombardi-Hill, D., et al. (2021) 2021 Guideline for the Prevention of Stroke in Patients with Stroke and Transient Ischemic Attack: A Guideline from the American Heart Association/American Stroke Association. Stroke, 52, e364-e467. [Google Scholar] [CrossRef] [PubMed]
[24] Xu, M., Chen, R., Liu, L., Liu, X., Hou, J., Liao, J., et al. (2021) Systemic Immune-Inflammation Index and Incident Cardiovascular Diseases among Middle-Aged and Elderly Chinese Adults: The Dongfeng-Tongji Cohort Study. Atherosclerosis, 323, 20-29. [Google Scholar] [CrossRef] [PubMed]
[25] Ridker, P.M. (2016) From C-Reactive Protein to Interleukin-6 to Interleukin-1: Moving Upstream to Identify Novel Targets for Atheroprotection. Circulation Research, 118, 145-156. [Google Scholar] [CrossRef] [PubMed]
[26] Song, J., Hwang, J., Ko, H., Park, J., Hong, H. and Kim, A. (2024) Exploring the Correlation between Systemic Inflammatory Markers and Carotid Atherosclerosis Indices in Middle-Aged Adults: A Cross-Sectional Study. Journal of Cardiovascular Development and Disease, 11, Article 73. [Google Scholar] [CrossRef] [PubMed]
[27] Libby, P. (2020) Inflammation in Atherosclerosis—No Longer a Theory. Clinical Chemistry, 67, 131-142. [Google Scholar] [CrossRef] [PubMed]
[28] Nappi, F. (2023) To Gain Insights into the Pathophysiological Mechanisms of the Thrombo-Inflammatory Process in the Atherosclerotic Plaque. International Journal of Molecular Sciences, 25, Article 47. [Google Scholar] [CrossRef] [PubMed]
[29] Ross, R. (1993) The Pathogenesis of Atherosclerosis: A Perspective for the 1990s. Nature, 362, 801-809. [Google Scholar] [CrossRef] [PubMed]
[30] Gonzalez, N.R., Liebeskind, D.S., Dusick, J.R., Mayor, F. and Saver, J. (2012) Intracranial Arterial Stenoses: Current Viewpoints, Novel Approaches, and Surgical Perspectives. Neurosurgical Review, 36, 175-185. [Google Scholar] [CrossRef] [PubMed]
[31] Ridker, P.M., Danielson, E., Fonseca, F.A.H., Genest, J., Gotto, A.M., Kastelein, J.J.P., et al. (2008) Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein. New England Journal of Medicine, 359, 2195-2207. [Google Scholar] [CrossRef] [PubMed]
[32] Katsanos, A.H., Palaiodimou, L., Price, C., Giannopoulos, S., Lemmens, R., Kosmidou, M., et al. (2020) Colchicine for Stroke Prevention in Patients with Coronary Artery Disease: A Systematic Review and Meta‐Analysis. European Journal of Neurology, 27, 1035-1038. [Google Scholar] [CrossRef] [PubMed]
[33] Nidorf, S.M., Eikelboom, J.W., Budgeon, C.A. and Thompson, P.L. (2013) Low-Dose Colchicine for Secondary Prevention of Cardiovascular Disease. Journal of the American College of Cardiology, 61, 404-410. [Google Scholar] [CrossRef] [PubMed]
[34] Koenig, W. and Nitschmann, S. (2021) [Colchicine in Patients with Coronary Heart Disease: LoDoCo2 Trial]. Der Internist, 62, 333-336. [Google Scholar] [CrossRef] [PubMed]